Jukka Koskela

3.7k total citations · 1 hit paper
23 papers, 748 citations indexed

About

Jukka Koskela is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Jukka Koskela has authored 23 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 7 papers in Physiology. Recurrent topics in Jukka Koskela's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Asthma and respiratory diseases (4 papers). Jukka Koskela is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Asthma and respiratory diseases (4 papers). Jukka Koskela collaborates with scholars based in Finland, United States and United Kingdom. Jukka Koskela's co-authors include Tarja Laitinen, Aarno Palotie, Samuli Ripatti, Witold Mazur, Tuomo Kiiskinen, Aki S. Havulinna, Veikko Salomaa, Mark J. Daly, Nina Mars and Jing Gao and has published in prestigious journals such as Nature Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Jukka Koskela

21 papers receiving 730 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers

2020 245 citations Nina Mars, Jukka Koskela et al. Nature Medicine profile →

Peers

Countries citing papers authored by Jukka Koskela

Since Specialization

Citations

This map shows the geographic impact of Jukka Koskela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jukka Koskela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jukka Koskela more than expected).

Fields of papers citing papers by Jukka Koskela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jukka Koskela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jukka Koskela. The network helps show where Jukka Koskela may publish in the future.

Co-authorship network of co-authors of Jukka Koskela

This figure shows the co-authorship network connecting the top 25 collaborators of Jukka Koskela. A scholar is included among the top collaborators of Jukka Koskela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jukka Koskela. Jukka Koskela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic associations between serotonin receptor 1F (HTR1F) regulatory variation and sleep apnoea in non-obese individuals: insights from GWAS and eQTL analyses 2025 ·European Respiratory Journal ·Satu Strausz, Martin Broberg, Samuel E. Jones, Jukka Koskela, Tuomo Kiiskinen, (unknown), Aarno Palotie, Tuula Palotie, Adel Bachour, Richa Saxena, Samuli Ripatti, Erik Abner, Hanna M. Ollila	0
2	Genetic Analysis of Obstructive Sleep Apnea and Its Relationship with Severe COVID-19 2024 ·Annals of the American Thoracic Society ·Satu Strausz, (unknown), (unknown), Tuomo Kiiskinen, Martin Broberg, Sanni Ruotsalainen, Jukka Koskela, Adel Bachour, Tamar Sofer, Daniel J. Gottlieb, Aarno Palotie, Tuula Palotie, Samuli Ripatti, Hanna M. Ollila	5
3	High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study 2024 ·American Journal of Psychiatry ·Juulia Partanen, Paavo Häppölä, Anders Kämpe, Ari Ahola‐Olli, (unknown), (unknown), (unknown), Jarmo Hietala, Olli Kampman, Jari Tiihonen, Antti Tanskanen, (unknown), (unknown), Mark J. Daly, (unknown), Aarno Palotie, Heidi Taipale, Markku Lähteenvuo, Jukka Koskela	13
4	KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis 2023 ·Respiratory Research ·Maria Hollmén, (unknown), Juulia Partanen, Jukka Koskela, Eva Sutinen, Riitta Kaarteenaho, Mari Ainola, Marjukka Myllärniemi	4
5	Face masks to prevent transmission of respiratory infections: Systematic review and meta-analysis of randomized controlled trials on face mask use 2022 ·PLoS ONE ·Hanna M. Ollila, Markku Partinen, Jukka Koskela, John Borghi, (unknown), Anna Rotkirch, (unknown)	14
6	Sleep apnoea is a risk factor for severe COVID-19 2021 ·BMJ Open Respiratory Research ·Satu Strausz, Tuomo Kiiskinen, Martin Broberg, Sanni Ruotsalainen, Jukka Koskela, Adel Bachour, (unknown), Aarno Palotie, Tuula Palotie, Samuli Ripatti, Hanna M. Ollila	74
7	OP0007 MUC5B PROMOTER VARIANT AND LONG-TERM INCIDENCE OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POPULATION BIOBANK STUDY OF 250,000 INDIVIDUALS 2021 ·Annals of the Rheumatic Diseases ·(unknown), Tarja Laitinen, Jukka Koskela, Aarno Palotie, Nina Mars	1
8	Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers 2021 ·Annals of the Rheumatic Diseases ·Antti Palomäki, Aarno Palotie, Jukka Koskela, Kari K. Eklund, Matti Pirinen, Samuli Ripatti, Tarja Laitinen, Nina Mars	29
9	Exome sequencing in patient‐parent trios suggests new candidate genes for early‐onset primary sclerosing cholangitis 2021 ·Liver International ·(unknown), Rinse K. Weersma, Maria E. Joosse, Barbara A. E. de Koning, Tim de Meij, Bart G.P. Koot, Victorien M. Wolters, Obbe F. Norbruis, Mark J. Daly, Christine Stevens, Ramnik J. Xavier, Jukka Koskela, Manuel A. Rivas, Marijn C. Visschedijk, Henkjan J. Verkade, (unknown), (unknown), Eleonora A. Festen, Patrick F. van Rheenen, Cleo C. van Diemen	6
10	Genomic prediction of alcohol-related morbidity and mortality 2020 ·Translational Psychiatry ·Tuomo Kiiskinen, Nina Mars, Teemu Palviainen, Jukka Koskela, Joel Rämö, Pietari Ripatti, Sanni Ruotsalainen, Aarno Palotie, Pamela A. F. Madden, Richard J. Rose, Jaakko Kaprio, Veikko Salomaa, Pia Mäkelä, Aki S. Havulinna, Samuli Ripatti	11
11	Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers breakdown → 2020 ·Nature Medicine ·(unknown), Nina Mars, Jukka Koskela, Pietari Ripatti, Tuomo Kiiskinen, Aki S. Havulinna, Joni V. Lindbohm, Ari Ahola‐Olli, Mitja Kurki, Juha Karjalainen, Priit Palta, Benjamin M. Neale, Mark J. Daly, Veikko Salomaa, Aarno Palotie, Elisabeth Widén, Samuli Ripatti	245
12	Geographic Variation and Bias in the Polygenic Scores of Complex Diseases and Traits in Finland 2019 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Sini Kerminen, Alicia R. Martin, Jukka Koskela, Sanni Ruotsalainen, Aki S. Havulinna, Ida Surakka, Aarno Palotie, Markus Perola, Veikko Salomaa, Mark J. Daly, Samuli Ripatti, Matti Pirinen	1
13	Geographic Variation and Bias in the Polygenic Scores of Complex Diseases and Traits in Finland 2019 ·The American Journal of Human Genetics ·Sini Kerminen, Alicia R. Martin, Jukka Koskela, Sanni Ruotsalainen, Aki S. Havulinna, Ida Surakka, Aarno Palotie, Markus Perola, Veikko Salomaa, Mark J. Daly, Samuli Ripatti, Matti Pirinen	68
14	472 - NUDT15 Variants Contribute to Thiopurine-Induced Myelosuppression in European Populations 2018 ·Gastroenterology ·G Walker, Jamie Harrison, Michiel Voskuil, Graham Heap, Neel Heerasing, Peter Hendy, Jukka Koskela, Mark J. Daly, Harry Sokol, Rinse K. Weersma, Dermot McGovern, Claire Bewshea, Michael N. Weedon, James Goodhand, Nicholas A. Kennedy, Tariq Ahmad	2
15	Individual FEV₁ Trajectories Can Be Identified from a COPD Cohort 2016 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Jukka Koskela, (unknown), Aleksi Kallio, Maritta Kilpeläinen, Ari Lindqvist, Tarja Laitinen	12
16	Characterization of sputum biomarkers for asthma–COPD overlap syndrome 2016 ·International Journal of COPD ·Jing Gao, Hiroshi Iwamoto, Jukka Koskela, Harri Alenius, Noboru Hattori, Nobuoki Kohno, Tarja Laitinen, Witold Mazur, Ville Pulkkinen	40
17	Physical activity in COPD patients decreases short-acting bronchodilator use and the number of exacerbations 2015 ·Respiratory Medicine ·(unknown), Jukka Koskela, Ari Lindqvist, Maritta Kilpeläinen, Tarja Laitinen	13
18	Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD 2014 ·BMC Pulmonary Medicine ·Jukka Koskela, Maritta Kilpeläinen, Henna Kupiainen, Witold Mazur, Harri Sintonen, Marike Boezen, Ari Lindqvist, Dirkje S. Postma, Tarja Laitinen	53
19	Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap 2013 ·European Respiratory Journal ·Hiroshi Iwamoto, Jing Gao, Jukka Koskela, Vuokko L. Kinnula, Hideo Kobayashi, Tarja Laitinen, Witold Mazur	94
20	Longitudinal HRQoL shows divergent trends and identifies constant decliners in asthma and COPD 2013 ·Respiratory Medicine ·Jukka Koskela, Henna Kupiainen, Maritta Kilpeläinen, Ari Lindqvist, Harri Sintonen, Janne Pitkäniemi, Tarja Laitinen	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact